Index RUT P/E - EPS (ttm) -2.24 Insider Own 30.51% Shs Outstand 37.39M Perf Week 11.24%
Market Cap 781.53M Forward P/E - EPS next Y -2.30 Insider Trans -2.72% Shs Float 30.84M Perf Month -13.21%
Enterprise Value 505.99M PEG - EPS next Q -0.64 Inst Own 33.64% Short Float 4.38% Perf Quarter 39.54%
Income -80.61M P/S 86.93 EPS this Y -19.43% Inst Trans 6.63% Short Ratio 1.89 Perf Half Y 213.90%
Sales 8.99M P/B 2.42 EPS next Y 14.17% ROA -24.66% Short Interest 1.35M Perf YTD 33.11%
Book/sh 7.28 P/C 2.78 EPS next 5Y -10.24% ROE -27.09% 52W High 24.00 -26.62% Perf Year 446.89%
Cash/sh 6.33 P/FCF - EPS past 3/5Y -24.49% -ROIC -29.38% 52W Low 2.88 511.46% Perf 3Y -
Dividend Est. - EV/EBITDA - Sales past 3/5Y - - Gross Margin 97.63% Volatility 6.65% 8.55% Perf 5Y -
Dividend TTM - EV/Sales 56.28 EPS Y/Y TTM -9.36% Oper. Margin -1031.46% ATR (14) 1.42 Perf 10Y -
Dividend Ex-Date - Quick Ratio 14.24 Sales Y/Y TTM - Profit Margin -896.11% RSI (14) 45.28 Recom 1.57
Dividend Gr. 3/5Y - - Current Ratio 14.24 EPS Q/Q -21.90% SMA20 -4.64% Beta 1.82 Target Price 53.33
Payout - Debt/Eq 0.02 Sales Q/Q - SMA50 -10.07% Rel Volume 0.39 Prev Close 17.53
Employees 62 LT Debt/Eq 0.01 Earnings Mar 24 BMO SMA200 64.41% Avg Volume 715.52K Price 17.61
IPO Sep 26, 2024 Option/Short Yes / Yes EPS/Sales Surpr. 2.49% 119.51% Trades
Volume 276,302 Change 0.46%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-27-26 Initiated Needham
Buy
$50
Feb-25-26 Initiated Oppenheimer
Outperform
$60
Feb-18-26 Upgrade Jefferies
Hold → Buy
$62
Jan-27-26 Initiated Piper Sandler
Overweight
$73
Dec-05-25 Upgrade Morgan Stanley
Underweight → Equal-Weight
$12
Oct-22-25 Upgrade Citigroup
Neutral → Buy
$10
Feb-28-25 Initiated William Blair
Mkt Perform
Dec-10-24 Downgrade Morgan Stanley
Overweight → Underweight
$40 → $5
Dec-09-24 Downgrade Jefferies
Buy → Hold
$42 → $7
Dec-09-24 Downgrade Citigroup
Buy → Neutral
$45 → $7
Oct-21-24 Initiated Morgan Stanley
Overweight
$40
Oct-21-24 Initiated Jefferies
Buy
$42
Oct-21-24 Initiated Citigroup
Buy
$45
Show Previous Ratings
Today 08:00PM
Mar-24-26 09:00AM
Feb-26-26 10:07PM
Feb-19-26 04:30PM
Jan-29-26 03:00AM
10:30PM
Loading…
Jan-21-26 10:30PM
(GlobeNewswire)
-5.63%
-6.06%
Jan-20-26 04:01PM
09:00AM
Jan-12-26 01:06PM
(Investor's Business Daily)
+27.23%
09:00AM
Dec-13-25 10:35AM
Dec-04-25 09:00AM
Nov-25-25 04:30PM
Nov-07-25 09:00AM
Nov-06-25 04:45PM
07:45AM
Loading…
Nov-05-25 07:45AM
Oct-29-25 06:15AM
Oct-26-25 06:33PM
Oct-23-25 07:36AM
Aug-20-25 04:30PM
Aug-18-25 07:36AM
Aug-15-25 09:00AM
Aug-06-25 04:30PM
Jul-29-25 10:23AM
Jun-21-25 06:00PM
Jun-17-25 09:00AM
Jun-03-25 09:00AM
May-30-25 09:05AM
May-29-25 11:18PM
09:00AM
04:30PM
Loading…
May-27-25 04:30PM
May-06-25 04:30PM
Apr-21-25 01:02PM
Mar-22-25 11:00AM
Mar-20-25 04:30PM
Mar-17-25 01:54PM
Mar-04-25 05:07AM
Feb-20-25 04:30PM
10:36AM
Feb-16-25 07:18AM
Feb-14-25 05:45AM
Feb-13-25 08:42AM
Feb-07-25 05:45AM
Jan-30-25 09:01AM
Jan-29-25 05:39AM
Jan-28-25 07:27PM
09:00AM
Jan-24-25 05:45AM
Jan-22-25 03:00AM
Jan-21-25 05:45AM
Jan-18-25 03:07AM
Jan-06-25 09:00PM
Jan-03-25 12:51PM
Jan-02-25 09:35AM
Jan-01-25 05:00AM
Dec-27-24 11:32AM
09:18AM
Dec-26-24 07:23AM
Dec-25-24 07:04AM
Dec-23-24 10:19AM
Dec-19-24 01:15PM
05:46AM
(Pharmaceutical Technology)
Dec-18-24 09:00AM
Dec-16-24 04:20PM
03:00AM
Dec-13-24 10:31AM
Dec-12-24 06:34PM
Dec-09-24 07:51PM
09:28AM
07:41AM
Dec-07-24 06:34AM
Dec-06-24 04:35PM
(GlobeNewswire)
+9.36%
-76.85%
Dec-05-24 04:30PM
Dec-04-24 04:47PM
Nov-21-24 04:30PM
Nov-12-24 11:01PM
Nov-07-24 04:30PM
(GlobeNewswire)
-10.11%
+7.61%
Nov-04-24 09:00AM
Oct-24-24 09:00AM
Oct-21-24 10:53AM
Oct-17-24 09:45AM
Oct-12-24 02:31PM
Oct-07-24 09:10PM
Oct-05-24 07:15AM
Oct-03-24 09:05AM
Oct-01-24 04:30PM
Sep-26-24 04:08PM
(Investor's Business Daily)
02:36PM
08:25AM
Sep-25-24 08:00PM
04:13PM
11:27AM
BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
RUBIN PAUL D Chief Medical Officer Apr 01 '26 Option Exercise 5.05 8,820 44,572 8,820 Apr 03 04:07 PM RUBIN PAUL D Chief Medical Officer Apr 01 '26 Sale 17.81 8,820 157,084 0 Apr 03 04:07 PM RUBIN PAUL D Officer Apr 01 '26 Proposed Sale 17.81 8,820 157,084 Apr 01 10:53 AM RUBIN PAUL D Chief Medical Officer Mar 02 '26 Option Exercise 4.77 7,433 35,470 7,433 Mar 03 04:46 PM RUBIN PAUL D Chief Medical Officer Mar 02 '26 Sale 20.30 7,433 150,890 0 Mar 03 04:46 PM GOLDSTEIN DOV A MD Chief Financial Officer Mar 01 '26 Option Exercise 4.38 3,542 15,514 33,033 Mar 03 04:44 PM RUBIN PAUL D Officer Mar 02 '26 Proposed Sale 20.03 7,433 148,883 Mar 02 10:17 AM RUBIN PAUL D Chief Medical Officer Feb 02 '26 Option Exercise 4.77 7,433 35,470 7,433 Feb 03 04:26 PM RUBIN PAUL D Chief Medical Officer Feb 02 '26 Sale 18.75 7,433 139,369 0 Feb 03 04:26 PM GOLDSTEIN DOV A MD Chief Financial Officer Feb 01 '26 Option Exercise 4.38 3,541 15,510 29,491 Feb 03 04:23 PM RUBIN PAUL D Officer Feb 02 '26 Proposed Sale 18.75 7,433 139,369 Feb 02 09:43 AM GOLDSTEIN DOV A MD Chief Financial Officer Jan 16 '26 Option Exercise 4.38 3,542 15,514 25,950 Jan 21 04:20 PM GOLDSTEIN DOV A MD Chief Financial Officer Jan 13 '26 Option Exercise 8.39 27,000 226,530 49,408 Jan 15 04:22 PM GOLDSTEIN DOV A MD Chief Financial Officer Jan 13 '26 Sale 19.70 27,000 531,828 22,408 Jan 15 04:22 PM Fortney Kristen Chief Executive Officer Jan 13 '26 Sale 18.12 233,107 4,223,036 976,949 Jan 15 04:20 PM Fortney Kristen 10% Owner Jan 13 '26 Proposed Sale 18.00 233,107 4,195,926 Jan 13 04:36 PM GOLDSTEIN DOV A MD Officer Jan 13 '26 Proposed Sale 19.70 27,000 531,828 Jan 13 04:16 PM RUBIN PAUL D Chief Medical Officer Jan 02 '26 Option Exercise 4.77 7,433 35,470 7,433 Jan 06 04:24 PM RUBIN PAUL D Chief Medical Officer Jan 02 '26 Sale 12.85 7,433 95,490 0 Jan 06 04:24 PM RUBIN PAUL D Officer Jan 02 '26 Proposed Sale 13.41 7,433 99,677 Jan 02 12:56 PM RUBIN PAUL D Chief Medical Officer Dec 09 '25 Option Exercise 6.57 18,000 118,260 18,000 Dec 11 04:21 PM RUBIN PAUL D Chief Medical Officer Dec 09 '25 Sale 12.00 18,000 216,000 0 Dec 11 04:21 PM RUBIN PAUL D Officer Dec 09 '25 Proposed Sale 12.00 18,000 216,000 Dec 09 11:23 AM RUBIN PAUL D Chief Medical Officer Dec 04 '25 Option Exercise 4.11 68,897 283,167 68,897 Dec 05 06:20 PM RUBIN PAUL D Chief Medical Officer Dec 04 '25 Sale 10.19 68,897 701,909 0 Dec 05 06:20 PM RUBIN PAUL D Officer Dec 04 '25 Proposed Sale 10.19 68,897 701,912 Dec 04 04:30 PM
